Absence of an effect of injectable and implantable progestin-only contraceptives on subsequent risk of breast cancer
- 31 May 2004
- journal article
- Published by Elsevier BV in Contraception
- Vol. 69 (5), 353-360
- https://doi.org/10.1016/j.contraception.2003.12.015
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Combined effect of oral contraceptive use and hormone replacement therapy on breast cancer risk in postmenopausal women.Cancer Causes & Control, 2003
- Relation of regimens of combined hormone replacement therapy to lobular, ductal, and other histologic types of breast carcinomaCancer, 2002
- Hormone replacement therapy regimens and breast cancer riskObstetrics & Gynecology, 2002
- Oral Contraceptives and the Risk of Breast CancerThe New England Journal of Medicine, 2002
- Estrogen and estrogen plus progestin act directly on the mammary gland to increase proliferation in a postmenopausal mouse modelJournal of Cellular Physiology, 2001
- Hormone Replacement Therapy with Estrogen or Estrogen plus Medroxyprogesterone Acetate Is Associated with Increased Epithelial Proliferation in the Normal Postmenopausal BreastJournal of Clinical Endocrinology & Metabolism, 1999
- Effects of conjugated estrogens, medroxyprogesterone acetate, and tamoxifen on the mammary glands of macaquesBreast Cancer Research and Treatment, 1998
- Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53 297 women with breast cancer and 100 239 women without breast cancer from 54 epidemiological studiesThe Lancet, 1996
- Effects of hormone replacement therapy on the mammary gland of surgically postmenopausal cynomolgus macaquesAmerican Journal of Obstetrics and Gynecology, 1996
- Toxicology of depot medroxyprogesterone acetateContraception, 1994